AI-mediated analysis of vaccinated patients affirms safety of SARS-CoV-2 vaccines

By | February 25, 2021
A new study provides a timely answer to many of these fears, by reporting on the results of an analysis of over 31,000 vaccine recipients with respect to immediate adverse effects, reported within 21 days, of the first and/or second doses of the vaccine.